Breaking News
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Aurora Rebrands German EU-GMP Production Hub, Doubles Flower Output
EDMONTON – Aurora Cannabis Inc. announced the completion of a ...
Tilray Brands Reports Fiscal Q1 2027 Financial Results
NEW YORK - LONDON – Tilray Brands Inc. reported that ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Ohio Sets New Package and Potency Limits for Cannabis Products
COLUMBUS – The Ohio Department of Commerce Division of Cannabis Control adopted the rule, which applies to products intended for direct sale to recreational consumers and medical patients. It generally bars products from exceeding 90% ...
Curaleaf Secures Australian Approval for Medical Cannabis Inhaler, Lists in New Zealand
LONDON – Curaleaf International, part of Curaleaf Holdings, Inc., in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Device (QMID) has been registered by Australia's Therapeutic Goods Administration (TGA) as a Class ...
BetterLife Closes $100M Offering for Neurological Drug Pipeline
VANCOUVER – BetterLife Pharma Inc. closed a US$100 million public offering, providing capital to take its lead candidate through Phase I and Phase II clinical trials for cluster headache and migraine. Deep Track Capital led ...
